Finanzwire Finanzwire
Basculer en Français
10706 Companies
229174 Keywords
157826 Articles
121734 Press releases
Headlines Articles Press releases Clairvoyant Therapeutics Remove
  1. Home
  2. Companies
  3. Clairvoyant Therapeutics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/03/2024 at 14:05, 2 years 3 months ago

    Clairvoyant Therapeutics Advances Psilocybin Clinical Trial for Alcohol Use Disorder

    Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder Regulatory Pathway
  • PRESS RELEASE

    published on 04/03/2024 at 14:00, 2 years 3 months ago

    Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

    Clairvoyant Therapeutics aims to commercialize psilocybin treatment for alcohol use disorder by 2025. Company's trial progressing well, expecting results in 2024 & financing round underway
    Commercialization Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder
    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 11/29/2023 at 13:00, 2 years 7 months ago

    Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 03/20/2023 at 12:00, 3 years 3 months ago

    First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
Accesswire
  • Published on 07/11/2026 at 02:50, 1 day 4 hours ago

    Alaska Energy Metals Reports on At-the-Market Equity Financing Program

  • Published on 07/11/2026 at 02:00, 1 day 5 hours ago

    Battery X Metals Presents Positive Preliminary Lithium-Ion Battery Rebalancing Trial Results Demonstrating Significant Estimated Driving Range Improvements and Accelerated Commercialization Progress of its Patent-Pending Lithium-Ion Battery Rebalancing Te

  • Published on 07/11/2026 at 02:00, 1 day 5 hours ago

    Discovery Energy Metals Announces Non-Brokered Private Placement Financing

  • Published on 07/11/2026 at 00:00, 1 day 7 hours ago

    Onco-Innovations Completes Analytical Reference Standard Preparation Program for ONC010’s API

  • Published on 07/11/2026 at 00:00, 1 day 7 hours ago

    LNG Energy Group Provides Operational Update

View all ACCESSWIRE
EQS Group
  • Published on 07/11/2026 at 04:00, 1 day 3 hours ago

    CUHK Achieves Top 20 Global Ranking in QS World University Rankings 2027

  • Published on 07/10/2026 at 18:50, 1 day 12 hours ago

    NNS acquires shares in OCI

  • Published on 07/10/2026 at 18:40, 1 day 12 hours ago

    AFX Surpasses $1.1 Billion in Total Trading Volume, Highlighting Capital Efficiency in On-Chain Derivatives

  • Published on 07/10/2026 at 17:45, 1 day 13 hours ago

    WYF Launches Global AI Talent Compact at AI for Good Global Summit 2026

  • Published on 07/10/2026 at 17:14, 1 day 13 hours ago

    Form 8.3 - SAFESTAY PLC: Opening Position Disclosure

View all EQS
Les Echos
  • Published on 07/10/2026 at 18:00, 1 day 13 hours ago

    Half-year liquidity contract statement for CEGEDIM

  • Published on 07/10/2026 at 17:45, 1 day 13 hours ago

    Half-year liquidity contract statement

  • Published on 07/10/2026 at 17:45, 1 day 13 hours ago

    HALF-YEAR LIQUIDITY CONTRACT STATEMENT

  • Published on 07/10/2026 at 10:34, 1 day 20 hours ago

    Number of shares and voting rights - June 2026 (In French only)

  • Published on 07/09/2026 at 18:00, 2 days 13 hours ago

    Second-quarter 2026 activity: +7% (vs. Q2 2025)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy